Skip to main content

Day: August 11, 2021

Vertex Announces Second Quarter 2021 Financial Results

KING OF PRUSSIA, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced financial results for its second quarter ended June 30, 2021. “Our performance reflects strong demand across all our segments and product lines this quarter, as global businesses, governments and communities work to emerge from this past year stronger than ever,” said David DeStefano, Vertex President and Chief Executive Officer. “We continue to execute on our strategy to accelerate global commerce, with investments in go-to-market expansion and our cloud platform driving revenues from our cloud business up 59.5% year-over-year in the second quarter.” Second Quarter 2021 Financial ResultsTotal revenues of $104.9 million, up 15.0% year-over-year. Software...

Continue reading

VSBLTY ENTERS INTO LICENSE AGREEMENT WITH RADAR USA FOR SECURITY PRODUCT OFFERING

Philadelphia, PA, Aug. 11, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) (the Company or “VSBLTY”), a leading software provider of security and retail analytics technology, today announced that it has entered into a license agreement (the “License Agreement”) with RADAR USA, Inc. (“RADAR USA”) to develop a security product offering and associated services for sale in the United States and Canada. RADAR USA was formed in 2021 as a collaboration between VSBLTY and RADAR APP in Mexico, where the security network deployment has reached 10,000 cameras. Jay Hutton, VSBLTY founder & CEO, said, “The licensing agreement with RADAR USA is a major step toward bringing effective and affordable security technology into U.S. and Canadian neighborhoods and making them safer. The collaborative...

Continue reading

Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website: https://ponstreatment.com, created to serve as a resource for U.S.-based patients and physicians. The website is designed to provide both audiences with information on the Company’s PoNS Treatment and enable them to connect with Helius to learn more information, ask questions and receive future updates. “We are pleased to expand our online resources for U.S.-based patients and physicians as we prepare to commercialize our PoNS technology during the first quarter of 2022,” said Dane Andreeff, President and Chief Executive Officer of Helius. “Building on this progress, we look forward...

Continue reading

FLYHT to Participate in the Q3 Investor Summit

CALGARY, Alberta, Aug. 11, 2021 (GLOBE NEWSWIRE) — FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) today announced that Bill Tempany, Interim CEO, and Alana Forbes, CFO, will present virtually at the Q3 Investor Summit on Tuesday, August 17, 2021, at 2:45 pm ET (12:45 pm MT). Management of FLYHT will also be available for one-on-one meetings with investors throughout the two-day event.DATE: Tuesday, August 17, 2021TIME: 2:45 pm ET (12:45 pm MT)LINK: https://zoom.us/webinar/register/WN_rJQwpKq4SQ2jQyoJxh6z3gAn archived webcast of the presentation will be made available at www.investorsummitgroup.com and in the Investors section of the FLYHT website at www.flyht.com/investors. For additional information or to schedule a meeting with FLYHT management, please register for the conference...

Continue reading

scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

Received minutes from Type C meeting with the FDA confirming alignment on path toward resubmission of FUROSCIX® NDA; no additional clinical data or device modifications required at this time; on track for resubmission in Q4 Announced positive top-line results from the FREEDOM-HF study demonstrating that average 30-day heart failure-related costs were reduced by $17,753 per study subject in the FUROSCIX arm compared to historically matched comparators Ended Q2 with cash, cash equivalents, restricted cash and investments of $90.2 million, sufficient to fund operations, as currently planned, into 2023; lowered 2021 net loss guidance to $30.0 to $34.0 million BURLINGTON, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have...

Continue reading

Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys

The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds and Series C round, led by Baxter, CareDx, and DaVita EDEN PRAIRIE, Minn., Aug. 11, 2021 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients’ lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO. The Company outlined clinical initiatives and operational expansions as part of its investment plan for 2021 and 2022 focused on their liver and kidney programs. The additional funding will help accelerate Miromatrix’ progress towards initiating a clinical...

Continue reading

GZ6G Technologies Announces OTCQB Uplisting Application Has Been Finalized and Welcomes William Procanik and Scott Hale to Board of Directors 

Las Vegas, Aug. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GZ6G Technologies (OTCMarkets: GZIC), the complete enterprise smart solutions provider for large venues and cities, announced that on August 6, 2021 it finalized its OTCQB uplisting application and hopes to have the OTC finalize the uplist process by Friday, August 20, 2021. In conjunction with the completion of the uplist application, GZ6G Technologies has appointed two new board members; Mr. Scott Hale and Mr. William Procanik. Both bring a wealth of experience in the business sector and will be a welcome addition to the future plans of the Company and its growth. “We’re one step closer to becoming a fully reporting Securities and Exchange Commission (“SEC”) issuer. We continue to meet our milestones and have chosen board members who are comprised of a dedicated...

Continue reading

Spotlite360 Secures Agreement with One of Colorado’s Longest-Established Cannabis Dispensary Operators to Facilitate Planned Multi-State Expansion

Picture 1In the third episode of “In My City: Denver”, a series produced by HipHopDX (a channel owned by Warner Music Group), Peak was featured as an iconic contributor to Denver’s music scene, with patronage from high-profile recording artists. This episode can be viewed by clicking the thumbnail above or by clicking here.DENVER and VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — SPOTLITE360 TECHNOLOGIES, INC. (“Spotlite360” or the “Company”) (CSE: LITE) (OTC: SPLTF) (Frankfurt: 87A) is pleased to announce that it has entered into a master terms agreement (the “Agreement”) with Peak Dispensary (“Peak”), a cannabis dispensary operator with locations in Denver and Sedgwick, Colorado, to develop scopes of work for the integration of the Company’s suite of technologies (the “Spotlite360 Technologies”)...

Continue reading

Royalty Pharma Reports Second Quarter 2021 Results

Strong growth in net cash provided by operating activities (GAAP) and Adjusted Cash Flow(2) Announced transactions of up to $2.8 billion in 2021, including $2.1 billion* in upfront payments Increased 2021 guidance: Adjusted Cash Receipts(1) expected to be $2,080 to $2,120 millionNEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the second quarter of 2021 and raised full-year 2021 guidance for Adjusted Cash Receipts(1) (a non-GAAP financial measure). “Since our initial public offering a little more than a year ago, we have announced acquisitions totaling $4.7 billion, which is a testament to the strength of our business model and leadership position in the rapidly growing biopharma royalty funding market,” said Pablo Legorreta, Royalty Pharma founder and Chief Executive...

Continue reading

AppHarvest Announces Q2 2021 Results, Plans for New Holding Company Structure to Capitalize on Growing Global Need for Controlled Environment Agriculture, Announces Non-Binding LOI for JV with Mastronardi Produce to Expand Farm Network, and Reaffirms Long-Term 2025 Outlook

Company delivered net sales of $3.1 million on 8.6 million pounds of tomatoes sold,concluding the abbreviated 2020 planting season Secured $91 million in new, non-dilutive financing from leading sustainability investor Equilibrium Capital and $75 million from Rabo AgriFinance with four farms under construction Company reaffirms long-term 2025 outlook reflecting expected benefits of proprietary technology, plans to launch value-added product line; reduces 2021 outlook based on operational ramp-up challenges and dedicating more production space to strategic investments AppHarvest President David Lee assumes operational responsibility with key seasoned executive recruits supporting AppHarvest 2.0 initiative MOREHEAD, Ky., Aug. 11, 2021 (GLOBE NEWSWIRE) — AppHarvest, Inc. (NASDAQ: APPH, APPHW), a leading AgTech company, public benefit...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.